These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25052352)

  • 1. [Haemoglobinopathy in the 21st century: incidence, diagnosis and heel prick screening].
    Suijker MH; Roovers EA; Fijnvandraat CJ; Dors N; Rodrigues Pereira R; Giordano PC; Verkerk PH; Peters M
    Ned Tijdschr Geneeskd; 2014; 158():A7365. PubMed ID: 25052352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and prevalence of hemoglobinopathies in children in The Netherlands].
    Rengelink-van der Lee JH; Schulpen TW; Beemer FA
    Ned Tijdschr Geneeskd; 1995 Jul; 139(29):1498-501. PubMed ID: 7630457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian Paediatric Surveillance Unit study of haemoglobinopathies in Australian children.
    Argent E; Emder P; Monagle P; Mowat D; Petterson T; Russell S; Sachdev R; Stone C; Ziegler DS
    J Paediatr Child Health; 2012 Apr; 48(4):356-60. PubMed ID: 22151185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic carrier screening for hemoglobinopathies: the situation in the Netherlands compared with England].
    van Rhee MA; Holm JP; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 May; 142(18):996-7. PubMed ID: 9623197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune].
    Schulpen TW; van der Lee JH; van der Most van Spijk MW; Beemer FA
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1019-22. PubMed ID: 9623203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Starting neonatal screening for haemoglobinopathies in The Netherlands.
    Giordano PC
    J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal/newborn haemoglobinopathy screening in Europe and Africa.
    Bain BJ
    J Clin Pathol; 2009 Jan; 62(1):53-6. PubMed ID: 19103862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case study of haemoglobinopathy screening in the Netherlands: witnessing the past, lessons for the future.
    Jans SM; van El CG; Houwaart ES; Westerman MJ; Janssens RJ; Lagro-Janssen AL; Plass AM; Cornel MC
    Ethn Health; 2012; 17(3):217-39. PubMed ID: 21819310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for haemoglobinopathies: the Brussels experience.
    Gulbis B; Tshilolo L; Cotton F; Lin C; Vertongen F
    J Med Screen; 1999; 6(1):11-5. PubMed ID: 10321364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of clinically significant anaemia and haemoglobinopathy in children requiring dental treatment under general anaesthesia: a retrospective study of 1000 patients.
    Mason C; Porter SR; Mee A; Carr C; McEwan T
    Int J Paediatr Dent; 1995 Sep; 5(3):163-7. PubMed ID: 9601237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [One year of neonatal screening for sickle-cell disease in Emma Children's Hospital/Academic Medical Center in Amsterdam].
    Heijboer H; van den Tweel XW; Peters M; Knuist M; Prins J; Heymans HS
    Ned Tijdschr Geneeskd; 2001 Sep; 145(37):1795-9. PubMed ID: 11582643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study.
    Yorke D; Mitchell J; Clow C; Nuguid E; Cadogan R; Sinclair D; Luscombe S; Rozen R; Meredith P; Esseltine D
    Clin Invest Med; 1992 Aug; 15(4):376-83. PubMed ID: 1516295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoglobinopathies in tribal populations of India.
    Ghosh K; Colah RB; Mukherjee MB
    Indian J Med Res; 2015 May; 141(5):505-8. PubMed ID: 26139765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates.
    Hickman M; Modell B; Greengross P; Chapman C; Layton M; Falconer S; Davies SC
    Br J Haematol; 1999 Mar; 104(4):860-7. PubMed ID: 10192451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising the screening for haemoglobinopathies in pregnancy planning.
    Nickel RS; Darbari DS; Martin B; Thaniel L; Stern H; Jacquot C
    Hum Fertil (Camb); 2023 Dec; 26(5):1334-1339. PubMed ID: 36942480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Danish national haemoglobinopathy screening programme: Report from 16 years of screening in a low-prevalence, non-endemic region.
    Gravholt EAE; Petersen J; Mottelson M; Nardo-Marino A; Rathe M; Olsen M; Holm C; Jørgensen FS; Birgens H; Glenthøj A
    Br J Haematol; 2024 Jan; 204(1):329-336. PubMed ID: 37694757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.